These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20487670)

  • 61. Excipient-drug interactions in parenteral formulations.
    Akers MJ
    J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Excipients, adverse drug reactions and patients' rights.
    Napke E
    CMAJ; 1994 Sep; 151(5):529-33. PubMed ID: 8069798
    [No Abstract]   [Full Text] [Related]  

  • 63. What are excipients doing in medicinal products?
    Drug Ther Bull; 2009 Jul; 47(7):81-4. PubMed ID: 19567843
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Contact allergy to cosmetics].
    Goossens A; Merckx L
    Allerg Immunol (Paris); 1997 Dec; 29(10):300-3. PubMed ID: 9479432
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Lactose in drugs and lactose malabsorption].
    Hansen WE
    Z Gastroenterol; 1998 Mar; 36(3):XXIV-XXV. PubMed ID: 9577913
    [No Abstract]   [Full Text] [Related]  

  • 66. [Allergic reactions to local anesthetics].
    Bellver J; de Andrés JA; Bolinches R
    Rev Esp Anestesiol Reanim; 1991; 38(2):128-9. PubMed ID: 1876738
    [No Abstract]   [Full Text] [Related]  

  • 67. Intravenous immunoglobulins: in-depth review of excipients and acute kidney injury risk.
    Dantal J
    Am J Nephrol; 2013; 38(4):275-84. PubMed ID: 24051350
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Dyes and preservatives. Food and drug additives as a cause of allergic reactions].
    Hagelund CH
    Tidsskr Nor Laegeforen; 1975 Oct; 95(30):1738-9. PubMed ID: 1188876
    [No Abstract]   [Full Text] [Related]  

  • 69. Medicines, excipients and dietary intolerances.
    Drug Ther Bull; 2016 Aug; 54(8):93-6. PubMed ID: 27516168
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.
    Shehab N; Lewis CL; Streetman DD; Donn SM
    Pediatr Crit Care Med; 2009 Mar; 10(2):256-9. PubMed ID: 19188870
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adverse reactions to the non-drug constituents of nebuliser solutions.
    Beasley R; Rafferty P; Holgate ST
    Br J Clin Pharmacol; 1988 Mar; 25(3):283-7. PubMed ID: 3358893
    [No Abstract]   [Full Text] [Related]  

  • 74. Problems presented by components of drug vehicles.
    Rogers ML; Barrett CW
    J Hum Nutr; 1976 Feb; 30(1):41-5. PubMed ID: 1026771
    [No Abstract]   [Full Text] [Related]  

  • 75. The safety of pharmaceutical excipients.
    de Jong HJ
    Therapie; 1999; 54(1):11-4. PubMed ID: 10216416
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pediatric allergy medications: review of currently available formulations.
    Scadding G
    Curr Med Res Opin; 2009 Aug; 25(8):2069-79. PubMed ID: 19580371
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Allergic contact dermatitis to propylene glycol in calcipotriene ointment.
    Fisher DA
    Cutis; 1997 Jul; 60(1):43-4. PubMed ID: 9252735
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Excipients in topical corticosteroid preparations in Canada.
    Searles GE; DesGroseilliers JP
    CMAJ; 1989 Sep; 141(5):399-405. PubMed ID: 2766179
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro hemolysis: guidance for the pharmaceutical scientist.
    Amin K; Dannenfelser RM
    J Pharm Sci; 2006 Jun; 95(6):1173-6. PubMed ID: 16639718
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Excipients and new topical forms in dermatology].
    Delattre L
    J Pharm Belg; 1993; 48(4):261-9. PubMed ID: 8410631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.